Core Insights - Enerpac Tool Group Corp. reported a 6% increase in consolidated net sales for the second quarter of fiscal 2026, reaching $154.8 million compared to $145.5 million in the prior year [5][9] - The company experienced organic sales growth of 2%, with a notable 6% increase in product sales within the Industrial Tool & Service (IT&S) segment, marking the highest growth in 10 quarters [3][5] - Net earnings for the quarter were $16.3 million, down from $20.9 million in the same period last year, resulting in diluted EPS of $0.31 compared to $0.38 [8][9] Financial Performance - Consolidated net sales for the six months ended February 28, 2026, totaled $299.0 million, up from $290.7 million in the previous year [4] - Adjusted EBITDA for the second quarter was $33.0 million, a slight decrease from $33.8 million year-over-year, with an adjusted EBITDA margin of 21.3% [10] - Selling, general and administrative expenses (SG&A) increased to $45.3 million, driven by restructuring charges of $3.3 million and M&A charges of $1.1 million [7] Segment Performance - Within the IT&S segment, product revenue increased by 6% organically, while service revenue declined by 17% due to market softness, particularly in the EMEA region [5][6] - Cortland Biomedical saw a significant organic sales growth of 27%, contributing positively to the overall sales performance [5] Strategic Developments - The company signed a five-year service contract with a major UK oil & gas customer, valued at several million dollars annually, which aligns with its focus on higher-margin business [3] - Enerpac launched six new products at ConExpo, including the recently acquired Hydra Pac diesel split flow pump, indicating ongoing innovation and product development [9] Outlook - The company has updated its full-year fiscal 2026 guidance, projecting net sales between $635 million and $650 million, with organic sales growth of 1% to 3% [12][13] - Adjusted EBITDA is expected to be in the range of $158 million to $163 million, with adjusted EPS projected between $1.85 and $1.92 [13]

Core Viewpoint - Millicom International Cellular S.A. is convening its annual general meeting (AGM) on May 20, 2026, to discuss key agenda items including the approval of financial reports, dividend distribution, and the election of directors [2][3]. Group 1: AGM Details - The AGM will take place at Luxembourg Marriott Hotel on May 20, 2026, at 1:00 p.m. CET [2]. - Shareholders must be registered with Broadridge by May 6, 2026, to participate and vote [9][10]. - The agenda includes the election of the chair, management reports, approval of annual accounts, and dividend distribution [5][6]. Group 2: Financial Performance and Dividend - Millicom reported a profit of USD 1,203,488,812 for the fiscal year ended December 31, 2025, with unappropriated net profits carried forward of USD 1,516,871,900 [31]. - The Board proposes a dividend of USD 3 per share, to be paid in four equal installments totaling approximately USD 507 million, scheduled for July 15, 2026, October 15, 2026, January 15, 2027, and April 15, 2027 [34][36]. - The company confirms sufficient reserves to distribute the proposed annual dividend, subject to no losses incurred from January 1, 2026 [36]. Group 3: Director Elections and Remuneration - The Board proposes to set the number of directors at eight and re-elect several current directors for a term ending at the 2027 AGM [43]. - Directors' remuneration for the period from the AGM to the 2027 AGM is proposed to remain unchanged, totaling approximately USD 1,017,500 [48][49]. Group 4: Auditor and Share Repurchase Plan - KPMG is proposed to be re-elected as the external auditor for a term ending at the 2027 AGM [50]. - A share repurchase plan is proposed to allow Millicom to repurchase up to 10% of its outstanding shares, providing flexibility for long-term capital allocation [51][53].

Core Insights - Inventronics Limited reported a significant improvement in financial performance for the year ended December 31, 2025, achieving net earnings of $282,000 compared to a net loss of $62,000 in 2024 [2][3] - The company's revenue increased to $8,247,000 in 2025, up from $6,309,000 in 2024, indicating a growth of approximately 30.7% year-over-year [2][3] - For Q4 2025, the company reported a net loss of $151,000 on revenue of $1,552,000, which is an improvement from a net loss of $242,000 on revenue of $1,304,000 in Q4 2024 [2][3] Financial Highlights - For the three months ended December 31, 2025, revenue was $1,552,000, a 19.0% increase from $1,304,000 in the same period of 2024 [3] - The basic earnings per share for the full year 2025 was 5.8 cents, a recovery from a loss of 1.3 cents per share in 2024 [2][3] - Working capital as of December 31, 2025, was $1,761,000, an increase from $1,536,000 in 2024 [4] Balance Sheet Highlights - Property, plant, and equipment decreased to $3,149,000 in 2025 from $3,244,000 in 2024 [4] - Long-term debt, excluding the current portion, decreased to $2,050,000 in 2025 from $2,250,000 in 2024, indicating improved financial stability [4] - Shareholders' equity increased to $2,581,000 in 2025 from $2,267,000 in 2024, reflecting a stronger financial position [4]

Core Insights - Rani Therapeutics has appointed Jesper Høiland as Head of Strategy, who has over 30 years of experience in global pharmaceutical leadership, particularly in obesity and metabolic disease [1][3][5] Company Overview - Rani Therapeutics is a clinical-stage biotherapeutics company focused on the oral delivery of biologics and drugs, utilizing its proprietary RaniPill capsule technology to replace subcutaneous injections and intravenous infusions [6] Leadership Appointment - Jesper Høiland will shape Rani's corporate and pipeline strategy, prioritizing internal programs and evaluating new therapeutic opportunities, while supporting business development efforts [2][5] - Høiland's previous roles include Global Commercial Officer at Ascendis Pharma and President and CEO of Radius Health, with significant experience in launching and commercializing therapies [3][4] Strategic Focus - Høiland expressed enthusiasm for Rani's platform, highlighting the potential of oral biologics to transform treatment paradigms, particularly in the obesity space [5] - The company aims to advance its pipeline and execute long-term strategies by identifying valuable opportunities and fostering strategic partnerships [5]

Core Insights - Dyadic International, Inc. reported its financial results for 2025, highlighting a strategic transition towards a commercially driven organization with a focus on expanding market access and product offerings [1][2]. Recent Company Developments and Updates - The commercial launch of AlbuFree™ DX recombinant human albumin by Proliant Health & Biologicals was announced, with Dyadic eligible for profit sharing from sales [5][6]. - Dyadic expanded its collaboration with Fermbox Bio, launching animal-origin-free recombinant DNase I as the first product under this partnership [5][6]. - An OEM distribution agreement was signed with IBT Bioservices to commercialize recombinant DNase I and transferrin for research and cell culture applications [5][6]. - A development and commercialization agreement with BRIG Bio was established to produce animal-free bovine alpha-lactalbumin for global nutrition markets [5][6]. - Inzymes plans to commercialize recombinant non-animal bovine chymosin in 2026 after meeting development milestones [11]. Financial Highlights - Total revenue for 2025 decreased to $3.09 million from $3.50 million in 2024, primarily due to a $638,000 reduction in research and development revenue [13]. - Grant revenue increased by $1.86 million in 2025, attributed to funding from the Gates Foundation and CEPI [13]. - The net loss for 2025 was $7.36 million, or $(0.23) per share, compared to a net loss of $5.81 million, or $(0.20) per share, in 2024 [16][25]. - Cash and cash equivalents as of December 31, 2025, were approximately $4.62 million, down from $6.51 million in 2024 [12][27]. Corporate Development - Dyadic rebranded as Dyadic Applied BioSolutions and launched a redesigned corporate website to enhance product commercialization and customer engagement [9]. - The company is expanding commercial efforts in Asia, particularly in Japan and South Korea, to facilitate market entry for its animal-free proteins [9]. - Dyadic is participating in various government- and partner-supported programs, including initiatives for vaccine development and pandemic preparedness [11].

Core Viewpoint - Pelican Acquisition Corporation has successfully completed its business combination with Pelican Holdco, Inc., Greenland Exploration Limited, and March GL Company, resulting in the formation of Greenland Energy Company, which will focus on responsible development of Greenland's natural resources to enhance global energy security [1][6][8] Company Overview - Greenland Energy will commence trading on The Nasdaq Stock Market under the ticker symbol "GLND" on March 26, 2026 [1] - The company has secured rights to own up to 70% of three onshore licenses in the Jameson Land Basin, covering over 2,000,000 acres [6][7] Exploration and Development Potential - The Jameson Land Basin has significant hydrocarbon potential, with independent engineering reports estimating recoverable oil resources in the range of 13 billion barrels [6][7] - Greenland Energy has identified over 50 distinct oil and gas targets in the basin through modern reprocessing of legacy seismic data [3] Infrastructure and Logistics - The Greenland Government has approved the mobilization of heavy equipment to support drilling operations, including a D9 bulldozer and other machinery [4] - Greenland Energy has partnered with Halliburton for logistics planning and drilling services, and secured a 3,500-meter-capable drilling rig [5] Leadership and Governance - The leadership team of Greenland Energy includes Larry G. Swets, Jr. as Executive Chairman and Robert Price as Chief Executive Officer, with representatives from Greenland, March GL, and Pelican [10] Financial Aspects - The business combination has an implied valuation of $215 million for Greenland Energy [6] - Existing shareholders of Greenland Exploration and March GL will receive a total of 1,500,000 and 20,000,000 shares of Greenland Energy common stock, respectively [13]

Core Viewpoint - SPARC AI Inc. has appointed a Ukraine-based referral agent to enhance its engagement with Ukrainian defense stakeholders, aiming to accelerate the deployment of its Overwatch GPS-denied navigation and target acquisition platform in a highly contested battlefield environment [1][5]. Group 1: Appointment of Referral Agent - The referral agent operates within Ukraine and has established relationships with active defense personnel, providing SPARC AI with unique access and intelligence that remote engagement cannot replicate [2]. - This appointment is a non-exclusive arrangement designed to complement existing partnerships and the company's drone testing program in Ukraine [2][5]. Group 2: Overwatch Platform Capabilities - SPARC AI's Overwatch platform offers AI-enabled position assurance and target acquisition capabilities in environments where GPS is denied, degraded, or jammed, making it suitable for the challenging operational conditions faced by Ukrainian forces [3]. - The operational theater in Ukraine is characterized by significant electronic warfare challenges, including pervasive GPS jamming and spoofing [3]. Group 3: Agent's Role and Compliance - The agent's responsibilities include identifying and facilitating introductions to Ukrainian defense procurement personnel and operational units that are evaluating autonomous systems technology for immediate deployment [4]. - All engagements facilitated by the agent will adhere to SPARC AI's standard commercial processes, compliance frameworks, and applicable export control requirements [4]. Group 4: Expansion of Commercial Footprint - The appointment of the referral agent is part of SPARC AI's broader strategy to expand its international commercial footprint and convert technical validation work into active commercial agreements [5]. - The company will provide updates as commercial engagements progress, although specific details about the referral agent and defense contacts cannot be disclosed due to operational security sensitivities [5]. Group 5: Company Overview - SPARC AI is a defense technology company focused on solving critical challenges in modern autonomous systems, particularly in accurate navigation and targeting when GPS is unavailable [6]. - The company's AI-powered platform transforms low-cost inertial sensors in commercial drones into precision instruments, making GPS-denied capabilities accessible at a competitive price point [6].

Core Viewpoint - Air Canada is actively providing support to passengers and crew involved in the incident of Air Canada Express flight 8646, which occurred on March 22, 2026, with four individuals still hospitalized [1]. Group 1: Incident Response - The Air Canada Special Assistance Team is stationed in New York to assist passengers, crew, and their families following the incident [1]. - Air Canada's Maintenance teams are on-site in New York and will relocate the aircraft to a secured hangar once it is safe to do so [2]. - The process of reuniting passengers with their baggage and personal belongings will commence once the aircraft is in the hangar, although sorting and identifying items will take time [2]. Group 2: Investigation and Communication - Air Canada and Jazz Aviation are collaborating with the Transportation Safety Board of Canada and the National Transportation Safety Board in the investigation of the accident's cause [3]. - Family and friends seeking information about passengers on flight AC8646 can contact Air Canada at 1-800-961-7099 [3].

Core Insights - Freddie Mac released its Monthly Volume Summary for February 2026, detailing its mortgage-related portfolios, securities issuance, risk management, delinquencies, debt activities, and other investments [1] Group 1: Company Overview - Freddie Mac's mission is to make home ownership possible for families across the nation, promoting liquidity, stability, and affordability in the housing market throughout all economic cycles [2] - Since its inception in 1970, Freddie Mac has assisted tens of millions of families in buying, renting, or maintaining their homes [2]

Core Viewpoint - Dime has declared a quarterly cash dividend of $0.25 per share, continuing its trend of uninterrupted dividends [1]. Company Overview - Dime is a New York State-chartered trust company with approximately $15 billion in assets [2]. - The company holds the number one deposit market share on Greater Long Island, specifically in Kings, Queens, Nassau, and Suffolk counties for community banks with less than $20 billion in assets [2].